A woman claiming to be Turing Pharmaceuticals CEO Martin Shkreli’s ex-girlfriend alleges that he sent her messages on Facebook a few years after they broke up, offering her money for sex.
The woman, only identifying herself “Katie,” reached out to Business Insider about the messages on Tuesday, and then posted screenshots of the exchange to her blog (which is definitely NSFW) the following morning.
In the post, Katie says the conversation took place 2 years ago “before this whole biotech big pharma price gouging scandal blew up.”
(Click each image to enlarge)
“I had unfriended him after he solicited me for prostitution and wouldn’t stop pestering me,” Katie wrote. “Unbeknownst to me, his latest attempt came at around the same time he became CEO of Turing Pharmaceuticals. A friend in finance speculated the surprise contact could be explained by Martin’s sudden acquisition of cash to spend … on women.”
The screenshot below is from Shkreli’s work email according to Katie.
Katie wrote that she and Shkreli began dating when he was a 19-year-old junior analyst at Cramer Berkowitz. Starting in late 2004 according to her, he began sending her “unwanted” Facebook messages.
“In April 2008, a full 5-years after we had broken up, he sent me a Facebook message alleging, ‘95% of the time i get off i’m thinking about you,'” Katie recalled, adding that the messages “didn’t end there.”
Shkreli dismissed Katie’s claims, telling Business Insider that they didn’t “know the context” of the exchange. Shkreli also said the screenshots may have been “fabricated.”
“You can see it, but perhaps there’s some, you know, back and forth that you don’t have on an email address or something,” Shkreli said, referring to the screenshots. “Maybe I’m referring to something else. You know, it’s possible that it’s not what you think. It’s also possible it’s fabricated. I don’t know. I don’t have them. It’s from 2009. It’s a jilted lover or vice versa. It just doesn’t seem that meaningful.”
Shkreli kicked off an uproar earlier this week after purchasing the rights to Daraprim, a 62-year-old drug used for treating life-threatening parasitic infections in children and AIDS patients, and raising the price overnight from $13.50 per tablet to $750.
Featured image via Twitter